APO B CONTAINING LIPOPROTEINS A BETTER TARGET FOR CV RISK REDUCTION?
EAS Academy. Ference B. 05/07/18; 217762 Topic: Therapy
Brian A. Ference
Brian A. Ference
Contributions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies